Investors & Media

Sunesis is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel small molecule therapeutics for oncology and other unmet medical needs. We believe the quality and breadth of our product candidate pipeline, platform technology, strategic collaborations and scientific team will enable us to become a fully integrated biopharmaceutical company with a diversified portfolio of novel therapeutics for major diseases.

9:57 AM ET Aug 20, 2008
Price	$1.59
Change	- 0.04
Day Range	$1.59 - $1.59
Volume	300

Market data powered by TurboFeed.
Delayed at least 15 minutes.

Get a detailed stock quote

2007 Annual Report and Form 10-K
( PDF, 540.3 KB)
2007 Interactive Annual Report
( HTML)

Corporate Presentation.pdf
( PDF, 608.7 KB)

Latest News

Aug 7, 2008

Sunesis Pharmaceuticals Reports Financial Results for the Second Quarter 2008

Jul 29, 2008

Sunesis Pharmaceuticals to Report Financial Results for the Second Quarter on August 7, 2008

Jul 3, 2008

Sunesis Pharmaceuticals to Present at the Collins Stewart Fourth Annual Growth Conference

Jun 19, 2008

Sunesis Pharmaceuticals to Present at the Jefferies 2nd Annual Healthcare Conference

View all releases »

Sunesis is an innovative biopharmaceutical company focused on therapeutics for oncology and other unmet medical needs.

Listen to recent webcasts of presentation conference calls, earnings calls, and more.